|
Company:
|
PASSAGE BIO, INC. (PASG)
|
|
Form Type:
|
4
|
|
Filing Date:
|
3/25/2020
|
|
CIK:
|
0001787297
|
|
Address:
|
TWO COMMERCE SQUARE
2001 MARKET STREET, 28TH FLOOR
|
|
City, State, Zip:
|
PHILADELPHIA, Pennsylvania 19103
|
|
Telephone:
|
(267) 866-0312
|
|
Fiscal Year:
|
12/31
|
|
|
|
|
|
Last Trade
|
Last Trade:
$23.00
|
Change:
0.10 (0.44%)
|
Trade Time:
May 28
|
Market Cap:
$1.04B
|
|
|
|
|
|
|
Description of Business
|
|
We are a genetic medicines company focused on developing transformative
therapies for rare, monogenic CNS disorders with limited or no approved
treatment options. Our vision is to become the premier genetic medicines company
by developing and ultimately commercializing therapies that dramatically and
positively transform the lives of patients suffering from these life-threatening
disorders. To achieve our vision, we have assembled a world-class team whose
members have decades of collective experience in genetic medicines and rare
disease drug development and commercialization. The field of genetic medicine is
rapidly expanding and we believe we have a differentiated approach to developing
treatments for rare, monogenic CNS disorders that enables us to select and
advance product candidates with a higher probability of technical and regulatory
success. We have entered into a strategic research collaboration with Penn's
GTP, headed by Dr.
|
|
|
|